2/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial

2/2 通过远程医疗治疗患有多动症的母亲及其幼儿:I 型有效性实施混合试验

基本信息

  • 批准号:
    10790070
  • 负责人:
  • 金额:
    $ 36.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-15 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

Parental ADHD, present in 25-50% of families of children with ADHD and frequently untreated, interferes with effective parenting and predicts poor child developmental and behavioral treatment outcomes. Based on the literature and our own pilot data, we are randomly assigning parents with ADHD and their young at-risk children to one of two conditions: (1) stimulant medication for parents with ADHD followed by a child treatment strategy (CTS) beginning with behavioral parent training (BPT) with the added recommendation of child stimulant treatment if the child remains impaired or (2) a CTS without treatment for maternal ADHD on parent, child, and family outcomes. In line with the NIMH Strategic Framework for Addressing Youth Mental Health Disparities, the parent grant, a hybrid effectiveness-implementation trial comparing two intervention approaches for families in which a parent and child has ADHD, focuses on screening and family-based intervention in low-resource pediatric primary care settings and includes an existing mentoring component. This Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility Mentorship proposal is intended to expand the proposed research within the scope of the parent grant, while providing deeper independent research opportunities for members of our research team who meet NIH diversity criteria. Aims are: (1) To understand lived experiences of low-resource families in which the parent and child have ADHD; (2) To understand parent preferences for the different parenting skills/intervention modules; and (3) To explore predictors of treatment engagement in our sample.
父母ADHD,存在于25-50%的ADHD儿童家庭中,并且经常未经治疗, 干扰有效的养育,并预测儿童发育不良和行为 治疗结果。根据文献和我们自己的试点数据,我们随机分配 注意力缺陷多动症的父母和他们的年轻的危险儿童的两个条件之一:(1)兴奋剂 ADHD父母的药物治疗,然后是儿童治疗策略(CTS), 行为父母培训(BPT),增加了儿童兴奋剂的建议 治疗,如果孩子仍然受损或(2)CTS没有治疗母亲ADHD, 父母,孩子和家庭的结果。根据国家精神卫生战略框架, 青少年心理健康差异,父母补助金,混合有效性实施试验 比较两种针对父母和孩子都患有多动症的家庭的干预方法, 重点是在资源匮乏的儿科初级保健中进行筛查和基于家庭的干预 设置并包括现有的指导组件。本行政补充文件 表彰在多样性、公平性、包容性和可访问性方面的卓越表现 打算在母基金的范围内扩大拟议的研究,同时提供 为我们的研究团队成员提供更深入的独立研究机会, 多样性标准。目的:(1)了解贫困家庭的生活经验, 父母和孩子都有ADHD;(2)了解父母对不同孩子的偏好。 父母教养技能/干预模块;(3)探讨治疗参与的预测因素, 我们的样本

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transdiagnostic Implications of Parental Socialization of Child and Adolescent Emotional Development: Commentary and Future Directions.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREA CHRONIS-TUSCANO其他文献

ANDREA CHRONIS-TUSCANO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREA CHRONIS-TUSCANO', 18)}}的其他基金

2/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
2/2 通过远程医疗治疗患有多动症的母亲及其幼儿:I 型有效性实施混合试验
  • 批准号:
    10456647
  • 财政年份:
    2019
  • 资助金额:
    $ 36.42万
  • 项目类别:
2/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
2/2 通过远程医疗治疗患有多动症的母亲及其幼儿:I 型有效性实施混合试验
  • 批准号:
    10410008
  • 财政年份:
    2019
  • 资助金额:
    $ 36.42万
  • 项目类别:
2/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
2/2 通过远程医疗治疗患有多动症的母亲及其幼儿:I 型有效性实施混合试验
  • 批准号:
    9806227
  • 财政年份:
    2019
  • 资助金额:
    $ 36.42万
  • 项目类别:
2/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
2/2 通过远程医疗治疗患有多动症的母亲及其幼儿:I 型有效性实施混合试验
  • 批准号:
    10222503
  • 财政年份:
    2019
  • 资助金额:
    $ 36.42万
  • 项目类别:
2/2 Treating Mothers with ADHD and their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial
2/2 通过远程医疗治疗患有多动症的母亲及其幼儿:I 型有效性实施混合试验
  • 批准号:
    10664862
  • 财政年份:
    2019
  • 资助金额:
    $ 36.42万
  • 项目类别:
School-Based Depression Prevention for Adolescents with ADHD
多动症青少年的学校抑郁症预防
  • 批准号:
    9902950
  • 财政年份:
    2018
  • 资助金额:
    $ 36.42万
  • 项目类别:
School-Based Depression Prevention for Adolescents with ADHD: COVID-Impacted Supplement
多动症青少年的学校抑郁症预防:受新冠肺炎影响的补充品
  • 批准号:
    10356973
  • 财政年份:
    2018
  • 资助金额:
    $ 36.42万
  • 项目类别:
School-Based Depression Prevention for Adolescents with ADHD
多动症青少年的学校抑郁症预防
  • 批准号:
    9757820
  • 财政年份:
    2018
  • 资助金额:
    $ 36.42万
  • 项目类别:
Behavioral Activation to Reduce Problem Alcohol Use in College Students with ADHD
行为激活可减少多动症大学生的饮酒问题
  • 批准号:
    9333077
  • 财政年份:
    2015
  • 资助金额:
    $ 36.42万
  • 项目类别:
Behavioral Activation to Reduce Problem Alcohol Use in College Students with ADHD
行为激活可减少多动症大学生的饮酒问题
  • 批准号:
    8635457
  • 财政年份:
    2015
  • 资助金额:
    $ 36.42万
  • 项目类别:

相似海外基金

Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了